IntroDuctIon
Protein ubiquitination is an important post-translational modification (PTM) that is essential for regulating protein turnover through the ubiquitin-proteasome system. Ubiquitination occurs most commonly on the ε-amino group of protein lysine residues through the concerted action of activating (E1), conjugating (E2) and ligating (E3) enzymes 1 . As ubiquitin itself has seven lysine residues, substrates can be monoubiquitinated or polyubiquitinated, resulting in various ubiquitin chain lengths and topologies that may serve to specifically bind cellular proteins with distinct ubiquitin-binding domains 1, 2 .
Historically, the identification of protein ubiquitination sites by MS has proven to be challenging because of the low stoichiometry of ubiquitinated proteins, the size of the modification itself and the diversity in resulting ubiquitin chain types. To enhance the identification of low-abundance ubiquitinated proteins in complex samples, earlier studies have used overexpressed, affinity-tagged ubiquitin systems to aid in the enrichment and identification of ubiquitinated proteins 3, 4 . These methods rely on the enrichment of ubiquitinated proteins when ubiquitin is intact and bound to its substrate. After protein digestion, both formerly ubiquitinated peptides and nonubiquitinated peptides (from the enriched substrate proteins and the attached ubiquitin molecules) are present in the sample. The increased sample complexity resulting from the presence of nonubiquitinated peptides makes detection of specific sites of ubiquitination challenging. Protein-level enrichment methods have enabled the detection of several thousand putative, ubiquitinated substrate proteins, but they lack the necessary enrichment specificity to enable identification of large numbers of ubiquitination sites.
Robust, large-scale detection of endogenous ubiquitination sites by MS requires a technique that facilitates the specific enrichment of only the modified lysine-containing peptides of ubiquitinated substrate proteins. To this end, global analysis of protein ubiquitination has markedly improved with the commercialization of antibodies specific for the di-glycyl remnant produced on ubiquitinated lysine residues (K-ε-GG) after trypsin digestion [5] [6] [7] [8] .
Specifically, trypsin digestion of ubiquitinated proteins cleaves off all but the two C-terminal glycine residues of ubiquitin from the modified protein. These two C-terminal glycine (GG) residues remain linked to the ε-amino group of the modified lysine residue in the tryptic peptide derived from digestion of the substrate protein. The presence of the GG on the side chain of that lysine prevents cleavage by trypsin at that site, resulting in an internal modified lysine residue in a formerly ubiquitinated peptide. The K-ε-GG group is recognized and enriched by using an antibody specific to K-ε-GG (Fig. 1) . It should be noted that modification by the ubiquitin-like proteins Nedd8 and ISG15 also results ubiquitination is essential for the regulation of cellular protein homeostasis. It also has a central role in numerous signaling events. recent advances in the production and availability of antibodies that recognize the lys--Gly-Gly (K--GG) remnant produced by trypsin digestion of proteins having ubiquitinated lysine side chains have markedly improved the ability to enrich and detect endogenous ubiquitination sites by mass spectrometry (Ms). the following protocol describes the steps required to complete a large-scale ubiquitin experiment for the detection of tens of thousands of distinct ubiquitination sites from cell lines or tissue samples. specifically, we present detailed, step-by-step instructions for sample preparation, off-line fractionation by reversed-phase chromatography at pH 10, immobilization of an antibody specific to K--GG to beads by chemical cross-linking, enrichment of ubiquitinated peptides using these antibodies and proteomic analysis of enriched samples by lc-tandem Ms (Ms/Ms). relative quantification can be achieved by performing stable isotope labeling by amino acids in cell culture (sIlac) labeling of cells. after cell or tissue samples have been prepared for lysis, the described protocol can be completed in ~5 d.
Trypsin-generated peptides Figure 1 | Enrichment of K-ε-GG peptides using anti-K-ε-GG antibody. After the antibody has been chemically cross-linked to a protein A bead using DMP, peptides are individually enriched for K-ε-GG peptides using the anti-K-ε-GG antibody, which recognizes the di-glycyl remnant remaining on modified lysine residues after trypsin digestion.
in a GG remnant being retained on modified lysine residues, which makes ubiquitination, Nedd8ylation and ISG15ylation indistinguishable on the basis of the tryptic remnant. However, Kim et al. 7 have completed experiments in HCT116 cells showing that >94% of K-ε-GG sites are a result of ubiquitination as opposed to Nedd8ylation or ISG15ylation. The K-ε-GG enrichment method can be performed with SILAC-labeled samples to enable relative quantification of protein ubiquitination across differentially perturbed states 6, 9 .
The K-ε-GG-specific antibody has been used in a growing number of large-scale experiments, including those that studied the effects of proteasome or deubiquitinase inhibition on the ubiquitin landscape [5] [6] [7] 10 , that globally identified putative cullin-RING ligase substrates 11 and that specifically identified ubiquitinome alterations dependent on the ubiquitin ligase PARKIN 12 . In addition, a recent tissue-specific analysis of ubiquitination sites in mouse tissues revealed both regulation of core signaling pathways and tissue-specific networks by ubiquitination 13 . The K-ε-GGspecific antibody enables the analysis of protein ubiquitination in a site-specific manner, which has the potential to reveal the degree of site specificity or site promiscuity of E3 ligases for substrate lysine residues 4, 12 .
Our previous work presented a refined workflow for routine detection of tens of thousands of distinct ubiquitination sites from single samples through methodological improvements made to both the off-line sample fractionation step as well as the K-ε-GG enrichment step 6, 14 (Figs. 1 and 2) . Specifically, we showed that fractionation of samples by basic pH reversed-phase (bRP) chromatography before the enrichment of K-ε-GG peptides significantly increases the number of identified and quantified K-ε-GG sites in SILAC-labeled samples 6, 9, 14 (Fig. 2) . Our previous work also demonstrated that chemical cross-linking of the K-ε-GG-specific antibody to a solid support considerably reduces the contamination of antibody fragments and non-K-ε-GG peptides present in the final enriched samples (Figs. 1 and 3) 6 . The present protocol provides complete step-by-step instructions for implementing the procedural workflow for large-scale enrichment and identification of ubiquitinated peptides using MS. Figure 3 | Example of an SDS-PAGE gel used to evaluate the efficiency of antibody cross-linking to protein A beads. TFA eluates from ~30 µg of pre-and post-cross-linked anti-K-ε-GG antibody were analyzed by SDS-PAGE. After cross-linking, more than a tenfold decrease in staining density for heavy and light chains of the antibody is required for optimal results. Reproduced from Udeshi et al. 6 . Off-line HPLC system for bRP separation: Agilent 1100 series pump equipped with a degasser, autosampler and fraction collector Column for bRP separation. We use a Zorbax 300 Extend-C18 column (9.4 × 250 mm, 300 Å, 5 µm; Agilent) because the silica-based packing material is stable up to pH 11.5. If an alternative reversed-phase column is used for the bRP separation, ensure that the silica-based packing material is stable at high pH. Column should be periodically tested using a simple peptide mixture of the user's choice to monitor for unwanted peak broadening or shifts in retention time caused by column deterioration over time.
MaterIals

REAGENTS
Deep-well plates, 96 wells: 2-ml round-bottom wells (Whatman/GE Healthcare, cat. no. 7701-5200) Solid-phase extraction disk for StageTips: Empore C18 extraction disk (3M, cat. no. 98060402181 or cat. no. 98060402173) Nanospray column for online ultraperformance liquid chromatography (UPLC)-MS/MS analysis: Self-pack PicoFrit column, 360 µm outer diameter (o.d.) × 75 µm inner diameter (i.d.), 10 µm i.d. tip, 50 cm length (New Objective, cat. no. PF360-75-10-N-5); ReproSil-Pur 120 Å, C18-AQ, 1.9 µm (Dr. Maisch) LC system for online LC-MS analysis: Proxeon Easy-nLC 1000 (Thermo Fisher Scientific). We use a Proxeon Easy-nLC 1000 and operate under UPLC conditions; however, any LC instrument that can deliver nanoflow rates and can operate up to a pressure of 1,000 bar can be used for peptide separation. Lower pressure, non-UPLC conditions, can also be used for separations, but we have observed that the number of peptides identified in a given experiment decreases by at least 1.5-fold Nanospray column heater, 20 cm (Phoenix S&T, cat. no. PST-CH-20U) Column heater controller (Phoenix S&T, cat. no. PST-CHC) Mass spectrometer: Q Exactive or Orbitrap Velos system (Thermo Fisher Scientific)  crItIcal We use a Q Exactive mass spectrometer because we find it yields higher numbers of identified K-ε-GG peptides relative to the Orbitrap Velos or Orbitrap Elite systems. REAGENT SETUP Stock solutions for lysis buffer Stock solutions are: 1 M Tris HCl (pH 8.0), 1 M NaCl, 500 mM EDTA, 1 mg ml − 1 aprotinin, 2 mg ml − 1 Leupeptin, 100 mM PMSF in ethanol, 500 mM chloroacetamide or iodoacetamide, and 40 mM PR-619 in DMSO Urea lysis buffer Prepare urea lysis buffer to contain 8 M urea, 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 2 µg ml − 1 aprotinin, 10 µg ml − 1 leupeptin, 50 µM PR-619, 1 mM chloroacetamide or iodoacetamide and 1 mM PMSF.  crItIcal The urea lysis buffer should always be freshly prepared to prevent carbamylation of proteins. PMSF should be added to the lysis buffer immediately before use because the To increase the stoichiometry of ubiquitinated proteins, cells can be treated before lysis with a proteasome inhibitor such as MG-132, bortezomib or epoxomicin 5, 7, 16 . The type of proteasome inhibitor used as well as the treatment time and concentration will need to be individually optimized by the user for each experiment. It should be noted that prolonged treatment (>1 h) with proteasome inhibitors can make it difficult to differentiate ubiquitination sites that occur because of stress induced by inhibiting the proteasome from those sites involved in physiological cellular functions 17 .
For quantitative analyses, SILAC can be used to differentially label up to three cellular states in a single experiment following previously described protocols 5, 9, 18 . Note that the use of amine-reactive isobaric tags such as isobaric tags for relative and absolute quantification (iTRAQ) or tandem mass tags (TMT) reagents for quantification is not compatible with this protocol if peptides are labeled before K-ε-GG enrichment. iTRAQ or TMT reagents will label K-ε-GG sites, and we have found that the K-ε-GG-specific antibody will not recognize these labeled species. For tissue samples, we suggest starting with enough tissue to yield at least 5-10 mg of protein.
EQUIPMENT SETUP StageTip setup C18 StageTips are prepared in-house essentially as described by Rappsilber et al. 19 , by using Empore C18 extraction disks. We pack two plugs of C18 material into each StageTip. Nanoflow C18 column The nanoflow C18 column has dimensions of 360 µm o.d. × 75 µm i.d., a 10-µm-i.d. tip, and it contains 24-cm ReproSil-Pur 120-Å, C18-AQ 1.9-µm resin (we self-pack our nanoflow columns in-house using a pressure bomb at 1,000 p.s.i.). proceDure prepare lysates • tIMInG 60 min 1| Chill urea lysis buffer to 4 °C and add lysis buffer to the cell pellet (see Reagent Setup) to achieve a protein concentration of ≤5 mg ml − 1 . 
8|
To increase the number of fully cleaved peptides generated after enzymatic digestion, treat samples with endoproteinase LysC before trypsin digestion 20 . If a more-rapid digestion procedure is desired, move to Step 9 and complete only trypsin digestion. For LysC digestion, use an enzyme-to-substrate ratio of 1:50 (wt/wt) and digest for 2 h at RT while shaking.  crItIcal step Check the pH of the reaction using a pH indicator strip at the beginning and end of digestion to ensure that the pH is in the optimal range for both LysC and trypsin (pH 8-8.5).
9|
For trypsin digestion, use an enzyme-to-substrate ratio of 1:50 (wt/wt). Complete the trypsin digestion overnight at RT while shaking.
10| Quench the digestion reaction by adding TFA to the sample to a final amount of 0.1% (vol/vol) and vortex. Make sure that the pH of the solution is ≤3 using a pH indicator strip before desalting.
11|
Centrifuge the peptide solution for 5-10 min at 3,000g to remove precipitate (contains mainly urea). Transfer the supernatant into a new tube.
peptide desalting by spe • tIMInG ≥5 h 12| Use a 500-mg tC18 SepPak cartridge with a vacuum manifold to desalt peptide samples.  crItIcal step As has been previously described in the protocol by Villén and Gygi 21 , the choice of cartridge size should be based on sample input amount. Capacities for SepPak cartridges are 3-5% (wt/wt) of the sorbent weight 21 . We have observed that letting the cartridges run dry during washing or loading can increase sample losses during desalting from 5% to >20%.
13| Condition the cartridge with 5 ml of wash solvent 1 (see Reagent Setup).
14| Condition the cartridge with 5 ml of elution solvent.
15|
Equilibrate the cartridge with four washes of 5 ml of wash solvent 2.
16| Load the sample onto the cartridge in 5-ml aliquots. ? trouBlesHootInG 17| Wash the cartridge four times with 5 ml of wash solvent 2.
18| Elute peptides into 15-ml conical tubes with two washes of 3 ml of elution solvent.
19|
Dry the eluted peptides completely by lyophilization (preferred) or by vacuum centrifugation. We find that lyophilization tends to be more consistent at generating a dry, fluffy peptide sample that is easily reconstituted. However, we find that lyophilizing peptide samples can be two or three times slower than vacuum centrifugation.  pause poInt Dried samples are stable and can be stored at −20 or −80 °C for several weeks.
brp fractionation • tIMInG ≥ 3 h  crItIcal See Figure 2 for an overview of this section.
20|
Reconstitute peptide samples in bRP solvent A (see Reagents) to achieve a concentration <10 mg ml −1 , and then centrifuge the samples at 20,000g to remove any material that did not go into solution.
21|
For separation of peptides, use the gradient and flow rate settings outlined in the table below. Across the entirety of the bRP separation, a total of 96 2-ml fractions are collected at a flow rate of 3 ml min -1 . Before separating the peptide sample, a blank gradient should be run to wash and equilibrate the RP column. During the blank gradient wash, fractions do not need to be collected.  crItIcal step We use a Zorbax 300 Extend-C18 column (9.4 × 250 mm, 300 Å, 5 µm; Agilent) for separating 6-15 mg of total peptide. However, you must adjust the scale of the RP C18 column if you are using peptide amounts outside of this range. Do not store Zorbax 300 Extend columns at high pH for extended periods of time (multiple days) when the column is not in use, as this can permanently decrease column performance. ? trouBlesHootInG 22| Inject the samples onto the bRP column at a flow rate of 3 ml min -1 and separate them as described above. Collect fractions every 0.66 min in a 2-ml 96-well plate (Fig. 2) . The UV absorbance measurement can be monitored at 214 nm. ? trouBlesHootInG 23| After separation, pool the bRP fractions in a serpentine, noncontiguous manner (as described below and shown in Fig. 2 ) to generate eight final fractions 6, 14, 22, 23 . Specifically, to generate eight total fractions, every eighth fraction is combined (final fraction 1 = 1,9,17,25,33,41,49,57,65; final fraction 2 = 2,10,18,26,34,42,50,58,66; …). We find that extremely early and late eluting fractions contain few K-ε-GG peptides and, therefore we do not use these regions for generating the final pooled fractions 14 .  crItIcal step The fractions used for pooling are specific to our HPLC configuration. Depending on your LC configuration, the specific fractions used for pooling from the 96-well plate may shift relative to what is described above and shown in Figure 2 . At this step, a small amount (~5%) of each bRP fraction can be saved before pooling if analysis of the proteome is desired 6, 14 .
24| Lyophilize or vacuum centrifuge pooled fractions to dryness.  pause poInt Dried samples are stable and can be stored at −20 or −80 °C for several weeks.
chemical cross-linking of K-«-GG-specific antibody to beads • tIMInG 2 h  crItIcal See Figure 1 for an overview of this section.
25|
Wash the antibody-bound beads three times with 1 ml of antibody cross-linking wash buffer (see Reagent Setup). Note that the antibody, as provided, is noncovalently bound to agarose beads. At this step, a small amount of antibody (1-5 µg) can be taken aside to serve as a comparator if a quality-control gel is run after cross-linking is completed. We suggest completing this quality-control step when cross-linking of the antibody to beads is completed for the first time or a new batch of antibody is used.
26|
Resuspend the beads in 1 ml of antibody cross-linking buffer.  crItIcal step The antibody cross-linking buffer needs to be freshly prepared for each use.
? trouBlesHootInG
27|
Incubate the antibody beads in antibody cross-linking buffer for 30 min at RT with gentle end-over-end rotation. After cross-linking, if you plan to run a quality control gel to test the cross-linking efficiency, remove the same amount of antibody set aside for the gel in Step 24. Elute pre-and post-cross-linked antibody from the beads using 0.15% (vol/vol) TFA and completely dry the eluates. Reconstitute the dried eluate in 1-2× SDS-PAGE sample buffer and 20 mM DTT, and incubate the eluates at 96 °C for 5 min. Separate each eluted antibody sample by SDS-PAGE (Fig. 3) .
28|
Stop the cross-linking reaction by washing the beads twice with 1 ml of antibody blocking buffer. Resuspend the antibody in 1 ml of antibody blocking buffer, and then incubate the antibody for 2 h at 4 °C with gentle rotation. ? trouBlesHootInG 29| Wash the cross-linked antibody three times with 1.5 ml of IAP buffer (see Reagent Setup).  pause poInt Cross-linked antibody can be stored in 1× PBS/0.02% (wt/vol) sodium azide for several weeks at 4 °C. Figure 1 for an overview of this section.  crItIcal For all steps in the enrichment of K-ε-GG peptides except peptide elution, microcentrifuge tubes containing the sample and the antibody beads are kept on ice when not spinning. 
Immunoaffinity purification of K-«-GG peptides • tIMInG 2 h  crItIcal See
31|
Resuspend each dried peptide sample in 1.5 ml of ice-cold IAP buffer.
32|
After dissolving the peptides, ensure that the pH of the solution is ~7 by applying ~1 µl of the solution to a paper pH indicator strip.  crItIcal step If the pH of the peptide solution is not ~7, a 1 M Tris solution can be used to adjust the pH.
33|
Centrifuge the peptide samples at 20,000g for 5 min at 4 °C to remove any insoluble material.
34|
Transfer each bRP-pooled peptide sample into the corresponding microcentrifuge tube containing the antibody beads.
35|
Seal each microcentrifuge tube with Parafilm to avoid leakage. Incubate the IAPs for 1 h at 4 °C with gentle end-overend rotation.
36|
Centrifuge each IAP at 2,000g for 1 min, wait for the beads to completely settle to the bottom of the tube and remove the supernatant.  crItIcal step The supernatant contains all unbound, non-K-ε-GG peptides and can be saved for additional experiments such as enrichment of other PTMs or proteins.
37|
Wash the beads twice with 1.5 ml of ice-cold IAP buffer followed by three washes with ice-cold PBS. After adding each wash reagent to the IAPs, invert each microcentrifuge tube five times, centrifuge the tubes at 2,000g for 1 min, wait for the beads to completely settle to the bottom of the tube, and then remove the supernatant.  crItIcal step Washes should be completed as quickly as possible to avoid loss of K-ε-GG peptides.
38|
To elute K-ε-GG peptides, remove the final wash buffer, pipette 50 µl of IAP elution solution (see Reagent Setup) to the antibody beads, gently tap the bottom of the tube several times and let the tube stand at RT for 5 min.  crItIcal step We do not vortex samples during this step, as beads will stick to the side walls of the microcentrifuge tube and are difficult to recollect at the bottom of the tube after centrifugation.
39|
Centrifuge the samples at 2,000g for 1 min, wait for the beads to completely settle to the bottom of the tube and remove the supernatants containing the eluted peptides. Transfer the supernatants into clean microcentrifuge tubes. Take care to avoid pipetting antibody beads during this step.
40|
Repeat Steps 37 and 38.
stagetip desalting • tIMInG 1 h 41| Prepare eight StageTips for desalting the enriched K-ε-GG samples as described in Equipment Setup and in the protocol by Rappsilber et al. 19 .  pause poInt StageTips can be prepared in advance and stored in a covered pipette tip box for several months.
42|
Use StageTip adapters to place the StageTips on the top of 2-ml microcentrifuge tubes.  crItIcal step All centrifugation steps for StageTip desalting are completed at 3,000-4,000g for 3-5 min at RT or until all of the top-loaded solution has traversed the StageTip. Ensure that the flow-through does not touch the StageTips in 2-ml microcentrifuge tubes.
43|
Wash the StageTips once with 50 µl of StageTip wash solvent 1.
44|
Equilibrate the StageTip twice with 50 µl of StageTip wash solvent 2.
45|
Load the sample onto the equilibrated StageTip.
46|
Wash and desalt the sample twice with 50 µl of StageTip wash solvent 2.
47|
Elute the peptides into a clean microcentrifuge tube with 50 µl of StageTip elution solvent.
48|
Vacuum-centrifuge the StageTip eluates to dryness. We typically transfer StageTip eluates to HPLC autosampler vials before drying.
lc-Ms/Ms
• tIMInG 1 d 49| Reconstitute each K-ε-GG sample in 8 µl of 0.1% FA/3% (vol/vol) acetonitrile and place it in LC autosampler that is cooled to 4 °C.
50|
Set up the nanospray column with a column heater that is set to 50 °C.
51|
Analyze each K-ε-GG sample using the UPLC and MS method parameters outlined in the following two tables.
For each analysis, we typically inject 4 µl of each sample at a flow rate of 500 nl min -1 . 
Normalized collision energy 25 dd settings
Underfill ratio 5%
Charge exclusion Unassigned, 1, ≥7
Peptide match On
Exclude isotopes On Dynamic exclusion 20 s  crItIcal step The LC parameters described here are specific to high-pressure peptide separations using a nanospray column packed with 20-24 cm of ReproSil-Pur 1.9 µm, C18 resin. The MS parameters are specific for the analysis of samples using a Q Exactive mass spectrometer. If non-UPLC conditions are used and/or another MS system is used for analysis, the LC and MS parameters described will need to be adjusted. ? trouBlesHootInG protein digestion yields peptides with many missed cleavages Peptides containing many missed cleavages are difficult to identify using automated search algorithms. If high numbers of missed cleavages are observed, the pH of the digestion buffer used in Step 7 should be checked, as it may be higher or lower than the optimal range of pH 8-8.5, which will reduce the activity of LysC or trypsin. If >2 M urea was present in the sample before the addition of enzymes or if markedly aged enzymes were used in the protocol, poor digestion efficiency may also be observed. 6 . Note that ~79% of K-ε-GG peptides are found in only one bRP fraction. (c) Bar plot showing the average number of distinct K-ε-GG and non-K-ε-GG peptides found in total for the SILAC-based study 6 . Error bars show s.d.
ten times fewer light and heavy chain fragments relative to the antibody before cross-linking (Fig. 3) . 
low yield of K--GG peptides
After completing data analysis, if the yield of K-ε-GG sites is lower than expected, a number of parameters in the workflow should be checked, including digestion and cross-linking efficiencies. Issues with the K-ε-GG IP that can lead to poor recovery of K-ε-GG peptides include the loss of antibody beads during wash steps (Step 28), insufficient removal of MOPS buffer during PBS washes (Step 36) and age of the K-ε-GG-specific antibody. If large numbers of non-K-ε-GG peptides are identified after enrichment, insufficient washing of beads may have occurred. Poorly operating LC-MS systems can also lead to low numbers of identified K-ε-GG peptides.
• Step 52, data analysis: >1 d antIcIpateD results By using the protocol described above, we previously showed that 10,000 K-ε-GG sites can be identified and quantified in SILAC experiments using ≥5 mg of starting protein sample per SILAC state 6 . Our previous work also indicated that chemical cross-linking of the K-ε-GG-specific antibody to a solid support markedly reduces the deleterious effects incurred from the presence of antibody fragments and non-K-ε-GG peptides in enriched samples. A representative SDS-PAGE gel used to assess the cross-linking reaction is shown in Figure 3 (ref. 6) . After cross-linking, the amount of antibody eluted from protein A beads is reduced by >10×. We have also found that the reduction in sample complexity by off-line bRP fractionation before K-ε-GG enrichment (Fig. 2) is crucial for increasing the yield of K-ε-GG peptides 6 . A benefit of using the noncontiguous pooling scheme shown in Figure 2 is that each pooled bRP fraction has a uniform distribution of hydrophilic and hydrophobic peptides and therefore will contain similar numbers of K-ε-GG peptides, thereby taking maximum advantage of the available instrument duty cycle for sequencing ubiquitinated peptides (Fig. 4a) 6, 14, 22, 23 . A previous analysis of ubiquitination sites, completed in full biological triplicate, from SILAC-labeled Jurkat cells treated with either MG-132, PR-619 or left untreated showed that ~3,100 distinct K-ε-GG peptides are quantified in each bRP fraction and that non-K-ε-GG peptides make up <50% of the total number of quantified peptides in each fraction (Fig. 4a) 6 . We also observed that >75% of peptides typically separate into only one of the eight bRP fractions and therefore peptide co-elution interference is markedly reduced in the fractionated samples compared with an unfractionated sample (Fig. 4b) . Taken together, the ubiquitin workflow enabled the quantification and identification of ~20,000 distinct K-ε-GG sites from a single triple-encoded SILAC-labeled sample (Fig. 4c) 6 . Figure 5 shows an example annotated MS/MS spectrum of a K-ε-GG-modified peptide 6 .
